Per Bakke focuses on COPD, Internal medicine, Physical therapy, Spirometry and Genome-wide association study. His studies in COPD integrate themes in fields like Respiratory disease, Cohort study, Exacerbation, Severity of illness and Cohort. His Internal medicine study combines topics in areas such as Cardiology and Pathology.
His Physical therapy research incorporates elements of Randomized controlled trial, FEV1/FVC ratio, Obstructive lung disease, Proportional hazards model and Asthma. His Spirometry research is multidisciplinary, incorporating perspectives in Bronchopulmonary dysplasia, Provocation test, Bronchial hyperresponsiveness, Intensive care and Airway. His Genome-wide association study research includes elements of Lung cancer, Allele and Genetic association.
Per Bakke mainly investigates COPD, Internal medicine, Physical therapy, Asthma and Spirometry. His COPD research includes elements of Exacerbation, Immunology, Genome-wide association study and Cohort study. His Immunology research incorporates elements of Biomarker, Sputum and Case-control study.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Surgery and Cardiology. His Physical therapy research incorporates themes from Respiratory disease, Vital capacity, Quality of life, Confidence interval and Chronic cough. In his research on the topic of Asthma, Risk factor is strongly related with Odds ratio.
The scientist’s investigation covers issues in COPD, Internal medicine, Asthma, Pulmonary disease and Immunology. Per Bakke has included themes like Genome-wide association study, Cohort study, Exacerbation, Disease and Genetic association in his COPD study. As a member of one scientific family, Per Bakke mostly works in the field of Internal medicine, focusing on Cardiology and, on occasion, Increased risk.
His research in Asthma focuses on subjects like Sputum, which are connected to Neutrophilia, Biomarker and Lung. His studies in Pulmonary disease integrate themes in fields like MEDLINE, Lung function and Bioinformatics. His Immunology study combines topics in areas such as Phenotype, Pulmonary fibrosis, Genetic predisposition and Respiratory system.
COPD, Internal medicine, Sputum, Genome-wide association study and Cohort are his primary areas of study. His research in COPD intersects with topics in Pulmonary disease, Exacerbation, Disease and Cohort study. His work deals with themes such as Gastroenterology and Endocrinology, which intersect with Internal medicine.
His Sputum research is multidisciplinary, incorporating elements of Eosinophil, Asthma, Immunology, Proteome and Proteomics. The Genome-wide association study study combines topics in areas such as Odds ratio, Genetic association, Bioinformatics and Medical genetics. His Cohort study combines topics from a wide range of disciplines, such as Omics, Area under the curve, Obstructive lung disease and Severe asthma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Changes in forced expiratory volume in 1 second over time in copd
Jørgen Vestbo;Jørgen Vestbo;Lisa D. Edwards;Paul D. Scanlon;Julie C. Yates.
The New England Journal of Medicine (2011)
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.
Alvar Agustí;Lisa D. Edwards;Stephen I. Rennard;William MacNee.
PLOS ONE (2012)
A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci
Sreekumar G. Pillai;Dongliang Ge;Guohua Zhu;Xiangyang Kong.
PLOS Genetics (2009)
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers
J A Hardie;A S Buist;W M Vollmer;I Ellingsen.
European Respiratory Journal (2002)
Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Jason Z. Liu;Federica Tozzi;Dawn M. Waterworth;Sreekumar G. Pillai.
Nature Genetics (2010)
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression
G. Gudmundsson;T. Gislason;C. Janson;E. Lindberg.
European Respiratory Journal (2005)
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.
Bartolome R Celli;Nicholas Locantore;Julie Yates;Ruth Tal-Singer.
American Journal of Respiratory and Critical Care Medicine (2012)
Variants in FAM13A are associated with chronic obstructive pulmonary disease
Michael H. Cho;Nadia Boutaoui;Barbara J. Klanderman;Jody S. Sylvia.
Nature Genetics (2010)
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.
Joy Miller;Lisa D Edwards;Alvar Agustí;Per Bakke.
Respiratory Medicine (2013)
Gender differences in COPD: are women more susceptible to smoking effects than men?
Inga-Cecilie Sørheim;Ane Johannessen;Amund Gulsvik;Per S Bakke.
Thorax (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bergen
Brigham and Women's Hospital
University College London
University of Manchester
University of Colorado Denver
University of Bergen
University of British Columbia
Johns Hopkins University
Brigham and Women's Hospital
University of Barcelona
University of York
Lawrence Livermore National Laboratory
University of Stuttgart
Kyoto University
University of Yamanashi
University of Tartu
Centre national de la recherche scientifique, CNRS
University of Aberdeen
University of Bordeaux
The Ohio State University
Technical University of Denmark
Binghamton University
University of Iceland
Duke University
Syracuse University
University of Copenhagen